NewslettersNeural Cell News RRM2 Enhances MYCN-Driven Neuroblastoma Formation and Acts as a Synergistic Target With CHK1 Inhibition By lbeveridge - July 15, 2022 0 Researchers identified ribonucleotide reductase subunit M2 (RRM2) as a candidate dependency factor further supported by growth inhibition upon in vitro knockdown. [Science Advances] Full Article